Procept Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Procept Biorobotics Corp
PRCT Stock  USD 72.50  0.93  1.30%   
Procept Biorobotics financial statements provide useful quarterly and yearly information to potential Procept Biorobotics Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Procept Biorobotics financial statements helps investors assess Procept Biorobotics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Procept Biorobotics' valuation are summarized below:
Gross Profit
114.7 M
Profit Margin
(0.50)
Market Capitalization
3.9 B
Enterprise Value Revenue
18.7961
Revenue
199.8 M
There are currently one hundred twenty trending fundamental ratios for Procept Biorobotics Corp that can be evaluated and compared over time across competitors. All traders should check out Procept Biorobotics' recent fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Enterprise Value is likely to drop to about 1.4 B in 2025

Procept Biorobotics Total Revenue

164.45 Million

Check Procept Biorobotics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Procept Biorobotics' main balance sheet or income statement drivers, such as Net Interest Income of 2.2 M, Interest Income of 6.7 M or Depreciation And Amortization of 3.6 M, as well as many indicators such as Price To Sales Ratio of 15.89, Dividend Yield of 0.0 or PTB Ratio of 6.67. Procept financial statements analysis is a perfect complement when working with Procept Biorobotics Valuation or Volatility modules.
  
Check out the analysis of Procept Biorobotics Correlation against competitors.

Procept Biorobotics Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets272.6 M465.4 M158.4 M
Slightly volatile
Short and Long Term Debt Total63.5 M91.1 M40.8 M
Slightly volatile
Other Current Liabilities28.2 M26.9 M8.4 M
Slightly volatile
Total Current Liabilities55.5 M52.8 M18 M
Slightly volatile
Other Liabilities171 K180 K864.4 K
Slightly volatile
Property Plant And Equipment Net59.2 M56.3 M18.8 M
Slightly volatile
Current Deferred Revenue6.8 M6.5 M1.5 M
Slightly volatile
Accounts Payable16.3 M15.5 M4.5 M
Slightly volatile
Cash203.6 M295.8 M112.7 M
Slightly volatile
Non Current Assets Total65.4 M62.3 M22.4 M
Slightly volatile
Non Currrent Assets Other4.8 M4.6 M1.6 M
Slightly volatile
Other Assets1.091.15722.1 K
Very volatile
Long Term Debt48.4 M59 M33.5 M
Slightly volatile
Cash And Short Term Investments203.6 M295.8 M112.7 M
Slightly volatile
Net Receivables58.4 M55.6 M12.2 M
Slightly volatile
Common Stock Shares Outstanding48.8 M54.3 M44.6 M
Slightly volatile
Liabilities And Stockholders Equity272.6 M465.4 M158.4 M
Slightly volatile
Non Current Liabilities Total112.3 M70.2 M167.3 M
Slightly volatile
Inventory48 M45.7 M15.6 M
Slightly volatile
Other Current Assets4.6 M6 M2.3 M
Slightly volatile
Total Liabilities131.3 M111.6 M182.3 M
Slightly volatile
Property Plant And Equipment Gross63.6 M60.6 M19.6 M
Slightly volatile
Total Current Assets244.3 M403.2 M138.4 M
Slightly volatile
Net Working Capital218.1 M350.3 M122.2 M
Slightly volatile
Short Term Debt3.1 M3.1 M3.3 M
Pretty Stable
Intangible Assets1.4 M1.1 M2 M
Slightly volatile
Property Plant Equipment38.8 M37 M15.3 M
Slightly volatile
Short and Long Term Debt3.6 M4.1 M4.5 M
Slightly volatile
Capital Surpluse422.9 M475.8 M518.8 M
Slightly volatile
Deferred Long Term Liabilities1.2 M1.3 M1.5 M
Slightly volatile
Non Current Liabilities Other160 K180 K196.2 K
Slightly volatile

Procept Biorobotics Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Income6.7 M6.4 M2.1 M
Slightly volatile
Depreciation And Amortization3.6 M4.4 M3 M
Slightly volatile
Interest Expense4.6 M4.6 M2.3 M
Slightly volatile
Selling General Administrative70.4 M139.7 M49.2 M
Slightly volatile
Total Revenue164.5 M156.6 M39.8 M
Slightly volatile
Other Operating Expenses296.3 M282.2 M101.3 M
Slightly volatile
Research Development58.5 M55.7 M22.4 M
Slightly volatile
Cost Of Revenue78.7 M74.9 M22.8 M
Slightly volatile
Total Operating Expenses217.6 M207.3 M78.5 M
Slightly volatile
Reconciled Depreciation3 M3.6 M2.1 M
Slightly volatile
Income Tax Expense4.1 M4.2 M2.1 M
Slightly volatile
Non Operating Income Net Other96.8 K108.9 K118.7 K
Slightly volatile

Procept Biorobotics Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Net Borrowings1 M1.1 M17.2 M
Slightly volatile
Stock Based Compensation23.1 M22 M6.3 M
Slightly volatile
Begin Period Cash Flow152.1 M259.5 M78.4 M
Slightly volatile
Other Cashflows From Financing Activities5.2 M5.5 M42.6 M
Slightly volatile
Depreciation3.2 M4.4 M2.2 M
Slightly volatile
Capital Expenditures30.4 M29 M10.3 M
Slightly volatile
Change To Operating Activities10.6 M10.1 M3.7 M
Slightly volatile
Total Cash From Financing Activities124.7 M193 M70.2 M
Slightly volatile
End Period Cash Flow205.6 M299.3 M114 M
Slightly volatile
Change To Netincome18.6 M17.7 M4.7 M
Slightly volatile
Sale Purchase Of Stock3.1 M3.2 M133.8 M
Slightly volatile
Cash And Cash Equivalents Changes163.4 M183.8 M200.4 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio15.8916.72205
Slightly volatile
Days Sales Outstanding62.3211772.109
Slightly volatile
Stock Based Compensation To Revenue0.220.160.2676
Slightly volatile
Capex To Depreciation6.265.964.4361
Pretty Stable
EV To Sales14.4615.22202
Slightly volatile
Inventory Turnover1.091.471.2618
Slightly volatile
Days Of Inventory On Hand300256290
Slightly volatile
Payables Turnover6.795.555.8367
Pretty Stable
Research And Ddevelopement To Revenue0.390.411.5946
Slightly volatile
Capex To Revenue0.330.210.8216
Slightly volatile
Cash Per Share3.314.92.353
Slightly volatile
Days Payables Outstanding51.4768.0764.3876
Very volatile
Income Quality1.071.171.0307
Very volatile
Intangibles To Total Assets0.00330.00340.0254
Slightly volatile
Net Debt To EBITDA1.611.631.097
Slightly volatile
Current Ratio8.086.878.294
Pretty Stable
Receivables Turnover5.733.245.3459
Slightly volatile
Graham Number10.5215.5810.5721
Slightly volatile
Capex Per Share0.50.480.2095
Slightly volatile
Revenue Per Share2.722.590.7672
Slightly volatile
Interest Debt Per Share1.111.580.9128
Slightly volatile
Debt To Assets0.310.230.3329
Slightly volatile
Operating Cycle385405366
Very volatile
Days Of Payables Outstanding51.4768.0764.3876
Very volatile
Ebt Per Ebit1.161.121.0114
Slightly volatile
Quick Ratio7.446.097.4024
Pretty Stable
Net Income Per E B T0.850.971.0169
Pretty Stable
Cash Ratio9.616.447.2159
Slightly volatile
Cash Conversion Cycle315318299
Pretty Stable
Days Of Inventory Outstanding300256290
Slightly volatile
Days Of Sales Outstanding62.3211772.109
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.871.111.1249
Slightly volatile
Fixed Asset Turnover1.72.51.3444
Slightly volatile
Debt Ratio0.310.230.3329
Slightly volatile
Price Sales Ratio15.8916.72205
Slightly volatile
Asset Turnover0.320.30.1474
Slightly volatile

Procept Biorobotics Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.5 B1.8 B1.8 B
Very volatile
Enterprise Value1.4 B1.6 B1.8 B
Slightly volatile

Procept Fundamental Market Drivers

Cash And Short Term Investments257.2 M

Procept Upcoming Events

27th of February 2024
Upcoming Quarterly Report
View
25th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Procept Biorobotics Financial Statements

Procept Biorobotics shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Procept Biorobotics investors may analyze each financial statement separately, they are all interrelated. The changes in Procept Biorobotics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Procept Biorobotics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue6.5 M6.8 M
Total Revenue156.6 M164.5 M
Cost Of Revenue74.9 M78.7 M
Stock Based Compensation To Revenue 0.16  0.22 
Research And Ddevelopement To Revenue 0.41  0.39 
Capex To Revenue 0.21  0.33 
Revenue Per Share 2.59  2.72 
Ebit Per Revenue(0.72)(0.76)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Procept Stock Analysis

When running Procept Biorobotics' price analysis, check to measure Procept Biorobotics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procept Biorobotics is operating at the current time. Most of Procept Biorobotics' value examination focuses on studying past and present price action to predict the probability of Procept Biorobotics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procept Biorobotics' price. Additionally, you may evaluate how the addition of Procept Biorobotics to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY